Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

Schuster MG, Edwards JE Jr, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, Slotman G, Panzer H, Biswas P, Rex JH.

Ann Intern Med. 2008 Jul 15;149(2):83-90.

PMID:
18626047
2.

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.

Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA.

Ann Surg. 2001 Apr;233(4):542-8.

3.
4.

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T.

Crit Care Med. 1999 Jun;27(6):1066-72.

PMID:
10397206
5.

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O; AmarCand Study Group.

Crit Care Med. 2009 May;37(5):1612-8. doi: 10.1097/CCM.0b013e31819efac0.

PMID:
19325476
6.

The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.

Magill SS, Swoboda SM, Shields CE, Colantuoni EA, Fothergill AW, Merz WG, Lipsett PA, Hendrix CW.

Ann Surg. 2009 Apr;249(4):657-65. doi: 10.1097/SLA.0b013e31819ed914.

PMID:
19300221
7.

Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.

DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA.

J Crit Care. 2007 Sep;22(3):237-44. Epub 2007 Apr 10.

PMID:
17869975
8.

Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.

Winston DJ, Pakrasi A, Busuttil RW.

Ann Intern Med. 1999 Nov 16;131(10):729-37.

PMID:
10577295
9.

Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.

Nolla-Salas J, Sitges-Serra A, León-Gil C, Martínez-González J, León-Regidor MA, Ibáñez-Lucía P, Torres-Rodríguez JM.

Intensive Care Med. 1997 Jan;23(1):23-30.

PMID:
9037636
10.

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.

Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A.

Crit Care Med. 2004 Dec;32(12):2443-9.

PMID:
15599149
11.

Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.

Benjamin DK Jr, Hudak ML, Duara S, Randolph DA, Bidegain M, Mundakel GT, Natarajan G, Burchfield DJ, White RD, Shattuck KE, Neu N, Bendel CM, Kim MR, Finer NN, Stewart DL, Arrieta AC, Wade KC, Kaufman DA, Manzoni P, Prather KO, Testoni D, Berezny KY, Smith PB; Fluconazole Prophylaxis Study Team.

JAMA. 2014 May 7;311(17):1742-9. doi: 10.1001/jama.2014.2624.

12.

Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.

Reboli AC, Rotstein C, Kett DH, Maschio M, Cartier S, Chambers R, Tarallo M.

Pharmacoeconomics. 2011 Aug;29(8):705-17. doi: 10.2165/11584810-000000000-00000.

PMID:
21591820
13.

Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.

Faiz S, Neale B, Rios E, Campos T, Parsley E, Patel B, Ostrosky-Zeichner L.

Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):689-92. doi: 10.1007/s10096-008-0666-4. Epub 2008 Nov 15.

PMID:
19011913
14.

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.

Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH.

Crit Care Med. 2005 Sep;33(9):1928-35; quiz 1936.

PMID:
16148461
15.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
16.

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.

Kett DH, Shorr AF, Reboli AC, Reisman AL, Biswas P, Schlamm HT.

Crit Care. 2011;15(5):R253. doi: 10.1186/cc10514. Epub 2011 Oct 25.

17.

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.

Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S.

Ann Intern Med. 2005 Dec 20;143(12):857-69.

PMID:
16365467
18.

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R.

Clin Infect Dis. 2006 Apr 15;42(8):1179-86. Epub 2006 Mar 14.

19.

Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.

Parikh TB, Nanavati RN, Patankar CV, Rao S, Bisure K, Udani RH, Mehta P.

Indian Pediatr. 2007 Nov;44(11):830-7.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk